Add Yahoo as a preferred source to see more of our stories on Google. More Americans are overweight than ever before. The US is losing its battle against the bulge. New data from the Centers for ...

A study shows obesity trends have diverged across regions over the past four decades, though it is too early for drugs such as Ozempic to have had a measurable impact ...

The prevalence of obesity among adults has slightly decreased in the United States but remains higher than 10 years ago, new federal data shows. Among adults aged 20 and older, about 40.3% were ...

Although medications with glucagon-like peptide-1 (GLP-1) receptor agonist activity have transformed the management of obesity and shown substantial cardiometabolic benefits, unmet needs remain.

Obesity rates in the U.S. are projected to rise over the next decade, but lifestyle strategies that may help reverse the trend. Robert DEYRAIL/Gamma-Rapho via Getty Images A new report predicts that ...

Obesity often persists from childhood into adulthood, yet guidelines are segmented by age, lacking adolescent-specific recommendations. Discrepancies exist in BMI assessment, exercise, and dietary ...

A new genetic analysis using data from over five million people has provided a clearer understanding of the risk of going on to live with obesity. New research led by the Universities of Copenhagen ...

Every year, researchers crunch the data and map out where Americans are struggling most with weight – and the results aren’t random. The same states appear at the top of the list, year after year.

Here's the thing: obesity isn't distributed evenly across the globe. Some nations face staggering rates of weight-related health crises, while others maintain remarkably lean populations despite ...

Please provide your email address to receive an email when new articles are posted on . Findings from the SUMMIT trial demonstrated that the long-acting GLP-1/GIP receptor agonist tirzepatide reduced ...